ORLANDO, Fla., Aug. 23, 2006 (PRIMEZONE) -- RedChip Visibility, a division of RedChip Companies, announced that they have initiated research on Genesis Bioventures, Inc. (OTCBB:GBIW).
Leslie Richardson, RedChip Research Analyst, Level III CFA Candidate, wrote in the report:
"We have put a twelve month price target of $0.72 on GBIW. Our valuation is based on a combination of GBIW's products opening two new multi-billion dollar markets and the expected accelerated revenue growth for each product line. Our belief is that CEO Doug Lane has the leadership and drive to get both products to market and bring the business segments to breakeven within the next twelve months. We feel that GBIW's investment risk is balanced with its upside opportunities since no product development is needed, just the implementation of a targeted marketing program."
To receive a complimentary copy of the RedChip Visibility initial research for GBIW, please visit: http://www.redchip.com/visibility/about.asp?page=requestGBIW.
About RedChip Visibility(tm)
RedChip Visibility, a division of RedChip Companies Inc., writes fundamental research on small-cap companies. RedChip's success has been documented in Forbes, Barron's and the Wall Street Journal. RedChip Visibility(tm) provides small-cap companies' access to both professional and individual small-cap investors by holding conferences throughout the United States, producing online corporate visibility programs, and writing company sponsored research.
The RedChip Companies Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2761
RedChip Visibility Research Disclosure
Any opinions expressed herein are subject to change. RedChip Companies Inc. is an affiliate of the Aurelius Consulting Group, Inc. Genesis Bioventures, Inc. is a client of the Aurelius Consulting Group, Inc. and of RedChip Visibility, a division of RedChip Companies. GBIW paid RedChip Visibility $26,000 for the RedChip Research Report. The Aurelius Consulting Group, Inc. receives $6,500 per month and 60,000 shares of Rule 144 stock per quarter for investor relations services.